Gene · 8000
Papers1,687
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,687
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The mouse gastric surface epithelial cell and its response to early Helicobacter pylori infection. | Virulence | 2026 | 41824631 | PubTator, text mining | PubMed |
| Efficacy and immunomodulatory effect of Claudin18.2-specific IL-7/XCL1 armored CAR-T cells in digestive tract cancer: preclinical and clinical analysis. | Signal Transduct Target Ther | 2026 | 41803093 | PubTator, text mining | PubMed |
| Cell-Based Immunization Combined with Single-Round Cell Panning Enables Discovery of PSMA-Targeting Nanobodies from Phage Display Libraries. | Biomolecules | 2026 | 41750375 | PubTator, text mining | PubMed |
| Cell-surface targets for prostate cancer therapeutics. | Urol Oncol | 2026 | 41741268 | PubTator, text mining | PubMed |
| Obesogens in Prostate Cancer: An Endocrine and Metabolic Threat. | Curr Obes Rep | 2026 | 41739363 | PubTator, text mining | PubMed |
| Emerging therapies to overcome antiandrogen resistance and beyond in lethal prostate cancer. | J Natl Cancer Cent | 2026 | 41738039 | PubTator, text mining | PubMed |
| Advancing CAR-T therapy in prostate cancer: overcoming the tumor microenvironment and enhancing efficacy. | Front Oncol | 2026 | 41717407 | PubTator, text mining | PubMed |
| Targeting cancer stem cells as the most aggressive and tumor-initiating cells. | Transl Oncol | 2026 | 41604836 | PubTator, text mining | PubMed |
| Metabolic transitions along a moisture gradient in a poly-extreme high-altitude desert ecosystem within the Atacama Desert. | Environ Microbiome | 2026 | 41578357 | PubTator, text mining | PubMed |
| Integrated multi-omics analysis of prognostic model and immune microenvironment in intrahepatic cholangiocarcinoma. | Transl Oncol | 2026 | 41558145 | PubTator, text mining | PubMed |
| Neuro-related gene signatures predict prognosis in diffuse large B-Cell lymphoma and uncover TRPV2-mediated tumor microenvironment regulation. | Ann Hematol | 2026 | 41549103 | PubTator, text mining | PubMed |
| Molecular alteration profiles characterize intraductal carcinoma of the prostate. | Cancer | 2026 | 41457395 | PubTator, text mining | PubMed |
| Progress in targeted therapy for prostate cancer via cell surface proteins (Review). | Biomed Rep | 2026 | 41282505 | PubTator, text mining | PubMed |
Retraction notice to "Genetic variations of prostate stem cell antigen (PSCA) contribute to the risk of gastric cancer for Eastern Asians: a Meta-analysis based on 16792 individuals". [Gene 493 (2012) 83-91]. | Gene | 2026 | 41253636 | PubTator, text mining | PubMed |
| CAR-T therapy: Advances in respiratory diseases. | Chin Med J Pulm Crit Care Med | 2025 | 41551012 | PubTator, text mining | PubMed |
| Causal associations between human plasma proteins and prostate cancer identified by proteome-wide Mendelian randomization. | Elife | 2025 | 41247789 | PubTator, text mining | PubMed |
| Bispecific antibodies in metastatic castration-resistant prostate cancer: therapeutic strategies and frontier advances. | World J Urol | 2025 | 41236620 | PubTator, text mining | PubMed |
| Non-signaling but all important: how the linker, hinge, and transmembrane domains in the CAR hold it all together. | Front Immunol | 2025 | 41221288 | PubTator, text mining | PubMed |
| Pro-Inflammatory Protein PSCA Is Upregulated in Neurological Diseases and Targets β2-Subunit-Containing nAChRs. | Biomolecules | 2025 | 41154610 | PubTator, text mining | PubMed |
| Fine-tuning sequence to function deep learning models on large-scale proteomic data improves the accuracy of variant effect prediction. | bioRxiv | 2025 | 41040220 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8000/papers?page=2